BON and Tigerbone Group will collaborate across traditional Chinese medicine products, life sciences research, and nutritional functional foods Bon Natural Life Limited (BON), a leading provider of bio-ingredient solutions in…

BON and Tigerbone Group will collaborate across traditional Chinese medicine products, life sciences research, and nutritional functional foods

Bon Natural Life Limited (BON), a leading provider of bio-ingredient solutions in the natural, health, and personal care industries, announced it entered into a Cooperation Framework Agreement with Tigerbone Group Limited.  As part of this strategic initiative, the parties also announced plans to establish the “BON Cooperation and Development Committee,” which will serve as a central platform to advance collaboration in traditional Chinese medicine and life sciences through resource sharing and complementary strengths.

Pursuant to the Agreement, and based on principles of equality, voluntariness, resource sharing, complementary advantages, and mutual benefit, BON and Tigerbone Group will collaborate across traditional Chinese medicine products, life sciences research, and nutritional functional foods. Each party will retain its independent intellectual property rights and scientific research achievements, while jointly developing new products, technologies, and solutions to drive innovation and long-term value creation.

Since its founding in 2006, BON has focused on the bio-manufacturing of natural active ingredients and the development of health solutions, growing into a globally recognised supplier of plant extracts, functional food ingredients, and personal care active ingredients. The Company’s business footprint spans multiple regions, including China, North America, the European Union, Japan, and South Korea.

Tigerbone Group is a diversified investment holding company with significant industrial expertise and established market channels across traditional Chinese medicine, the broader health sector, and financial services.

Yongwei Hu, Chairman of BON, stated that the collaboration will integrate the respective brand and technological strengths of BON and Tigerbone Group, enabling resource consolidation and enhanced synergies. He added that the partnership represents a key step in BON’s strategic expansion into the integration of traditional Chinese medicine and the broader health industry, as well as an important component of its global growth strategy.

Hu further noted: “Under the guidance of the ‘BON Cooperation and Development Committee,’ we expect to cultivate highly competitive new product categories under the BON brand within the health technology sector and deliver more scientifically grounded, natural health solutions to consumers worldwide. Looking ahead, BON and Tigerbone Group will continue to explore new technologies and innovations based on their existing intellectual property to drive meaningful incremental market growth.”